Results 41 to 50 of about 32,554 (309)

Effect of trans-retinoic acid in the inhibition of cholesteatoma in guinea pigs [PDF]

open access: yes, 2008
Middle ear cholesteatoma affected more than 5 million people until the 80`s. Many animal models were used, unsuccessfully, to study an alternative therapy to cholesteatoma.
Antunes, Marcos Luiz   +3 more
core   +3 more sources

Analysis of histopathological aspects in acquired middle ear cholesteatoma [PDF]

open access: yes, 2008
Middle ear cholesteatomas are characterized by the presence of stratified squamous epithelium in this cavity with highly invasive properties causing bone destruction and it may lead to complications.
Alves, Adriana Leal   +3 more
core   +4 more sources

Introducing the "ChOLE" Classification and Its Comparison to the EAONO/JOS Consensus Classification for Cholesteatoma Staging.

open access: yesOtology and Neurotology, 2019
: Many previous attempts have been made to classify or categorize cholesteatomas. Recently, the European Academy of Otology and Neurotology and the Japanese Otological Society proposed a classification system based primarily on extension and ...
T. Linder   +4 more
semanticscholar   +1 more source

Acquired cholesteatoma [PDF]

open access: yesCanadian Medical Association Journal
Newsted, Daniel   +2 more
openaire   +3 more sources

Efficacy of Otoendoscopy for Residual Cholesteatoma Detection During Microscopic Chronic Ear Surgery

open access: yesJournal of International Advanced Otology
BACKGROUND: The aim of this article is to determine the efficacy of otoendoscopy during microscopic cholesteatoma surgery on residual cholesteatoma rates postoperatively.
Floor Couvreur   +3 more
doaj   +1 more source

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium

open access: yesMediators of Inflammation, 2010
The tumor suppressor CYLD is a deubiquitinating enzyme that inhibits activation of the NF-κB, which has key roles in inflammation and apoptosis. We hypothesized that CYLD may regulate the NF-κB signaling pathway in cholesteatoma.
Jae Yong Byun   +4 more
doaj   +1 more source

Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.

open access: yesPLoS ONE, 2020
Middle ear cholesteatoma is a destructive disease in which inflammation plays an important role in development and progression, and there are currently no biomarkers predicting prognosis or recurrence.
Shunsuke Miyake   +8 more
doaj   +1 more source

Recurrence of Cholesteatoma - A Retrospective Study Including 1,006 Patients for More than 33 Years

open access: yesInternational Archives of Otorhinolaryngology, 2019
Introduction Cholesteatomas are benign tumors consisting of skin, and growing inside a retraction pocket in the tympanic membrane. Cholesteatomas can occupy the entirety of the middle ear, and are known for their osteolytic capabilities.
P. Møller   +4 more
semanticscholar   +1 more source

Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis. [PDF]

open access: yesPLoS ONE, 2014
Cholesteatoma is the growth of keratinizing squamous epithelium in the middle ear. It is associated with severe complications and has a poorly understood etiopathogenesis.
Anders Britze   +4 more
doaj   +1 more source

Middle ear cholesteatoma in two cats diagnosed with the aid of video-otoscopy

open access: yesJournal of Feline Medicine and Surgery Open Reports, 2023
Case series summary The present report describes middle ear cholesteatoma in two cats and also the use of video-otoscopy and flushing to assist with the diagnosis.
Cristiane Bazaga Botelho   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy